AGP Executive Report
Last update: 3 hours agoResearch: Chinese scientists reported that noninvasive brain stimulation improved reward learning and depressive symptoms in people with subclinical depression, an early finding that needs further testing. Patient Safety: A six-year-old girl died during an experimental gene-editing trial in China; two researchers were dismissed after warnings about risks reportedly went unheeded. Drug Access: China has added CAR-T therapy and other innovative medicines to its national insurance coverage, potentially widening access to advanced cancer treatments. Global Health: Construction has begun on a Chinese-Zambian venture billed as Africa’s first cholera-vaccine manufacturing facility, aimed at boosting regional supply. Obesity: A new study supports assessing clinical obesity risks beyond BMI, adding to calls for more comprehensive diagnosis.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.